J&J threatened with sanctions over plan to rebate 340B drugs

yesterday 3

The HHS agency that oversees the 340B drug discount program is threatening Johnson and Johnson with steep fines — and loss of access to Medicare and Medicaid — if it stops giving hospitals upfront discounts.